arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Amphastar Pharmaceuticals, Inc.

AMPH

$20.75 ▲ +0.95 (+4.80%) at close

15 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Neutral

auto_awesome

Analytical Summary

Amphastar Pharmaceuticals, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $969.9M

Dividend Yield —

Revenue Growth -1.7% ↘

Op. Margin 19.5% ↘

ROIC 18.0% ↘

FCF / Share $2.59 ↘

Trailing P/E 9.9x

Price / Book —

FCF Yield 12.5%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$719.89M

↓ -1.7% —

Net Income Profit after all expenses

$98.09M

↓ -38.5% —

Operating Margin Operating profit as % of sales

19.5%

↓ -30.5% 74th

FCF / Share Free cash flow per share

$2.59

↓ -27.1% —

Long-Term Debt Long-term obligations

$619.71M

↑ +1.0% —

Health Breakdown

Profitability ↑

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	-1.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-121%)	13.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	29.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+264%)	14.0% Good → Good Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+75%)	25.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+214%)	8.5% Fair → Fair Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7%)	9.4% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17%)	22.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+184%)	-5.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-173%)	1.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-82%)	19.5% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+144%)	-8.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-205%)	12.4% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+55%)	—	—
EPS Growth YoY (%)	-36.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	15.4% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	51.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	44.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	4233.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-97.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-65.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	76.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-34.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-38.5% Weak ↓ Weak Declining Year-over-year change in net income	16.0% Good ↓ Good Declining Year-over-year change in net income	50.5% Excellent ↓ Excellent Declining Year-over-year change in net income	47.1% Excellent ↓ Excellent Declining Year-over-year change in net income	4327.4% Excellent Excellent Year-over-year change in net income	-97.1% Weak Weak Year-over-year change in net income	N/M	N/M	-65.4% Weak Weak Year-over-year change in net income	N/M	74.0% Excellent Excellent Year-over-year change in net income	N/M	-34.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-27.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	18.2% Good ↓ Good Declining Year-over-year change in free cash flow	124.4% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	-9.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	196.6% Excellent Excellent Year-over-year change in free cash flow	11196.2% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	-76.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	13.0% Good ↓ Good Declining Compound annual revenue growth over 3 years	18.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	15.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.1% Good ↑ Good Improving Compound annual revenue growth over 3 years	13.4% Good ↑ Good Improving Compound annual revenue growth over 3 years	8.1% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	5.4% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	4.5% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	3.6% Caution Caution Compound annual revenue growth over 3 years	7.2% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	15.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	17.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	16.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	15.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	11.4% Good ↑ Good Improving Compound annual revenue growth over 5 years	6.8% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	8.9% Good ↑ Good Improving Compound annual revenue growth over 5 years	5.1% Fair Fair Compound annual revenue growth over 5 years	3.3% Caution Caution Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	3.8% Caution ↓ Caution Declining Compound annual EPS growth over 3 years	36.3% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	356.3% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	21.8% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	—	-27.9% Weak Weak Compound annual EPS growth over 3 years	65.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	-9.5% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	19.5% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+30%)	28.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+87%)	30.6% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+104%)	21.5% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+44%)	16.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+6%)	3.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	-0.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-100%)	-2.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-120%)	-0.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-104%)	6.1% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-59%)	-2.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	-8.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-157%)	7.6% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-49%)	12.4% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-17%)	—
Effective Tax Rate (%) (%)	20.7% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.6% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.6% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.2% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.5% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	76.3% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	22.8% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	32.9% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-192.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.5% Caution ↓ Caution Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	73.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	41.0% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	31.1% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	30.1% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	13.6% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+14%)	21.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+82%)	21.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+78%)	18.3% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+53%)	14.2% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+18%)	0.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-97%)	15.2% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+27%)	-1.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-116%)	1.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-87%)	4.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-66%)	-1.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-109%)	-5.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	5.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-57%)	8.9% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-26%)	—
FCF Margin (%) (%)	16.8% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	23.5% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	22.6% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	13.1% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	16.1% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	0.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-2.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	6.7% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	16.69x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.63x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	18.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	28.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	26.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	111.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	10.1% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	0.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.8% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	8.6% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	13.0% Good → Good Stable Operating profit relative to total assets Optimal: > 10%	13.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	14.5% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	10.4% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	1.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	3.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	5.2% Caution Caution Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	—	—	—	13.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-98%)	12.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	-1.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	-0.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-106%)	-3.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	4.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	7.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-48%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Debt to Equity (x)	—	—	—	—	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.11x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	—	—	—	0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	—	—	—
Interest Coverage (x)	6.05x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	7.66x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	7.25x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	58.23x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	78.97x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	29.29x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-0.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-35.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	15.32x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-6.99x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	18.26x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	32.39x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$449.53M	$461.92M	$458.88M	$-79.46M	$-48.17M	$-46.72M	$-27.36M	$-86.34M	$-65.59M	$-72.35M	$-25.78M	$-25.15M	$-53.59M	$-50.21M	$-53.74M
Debt / EBITDA (x)	3.60x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.63x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.71x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.64x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.98x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.30x Fair Fair Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.60x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	9.12x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.82x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$15.40	$15.11	$13.35	$10.28	$9.16	$7.44	$6.86	$6.35	$5.21	$5.62	$5.59	$5.02	$5.93	$5.30	—
Basic EPS, GAAP (USD)	$2.10	$3.29	$2.85	$1.88	$1.30	$0.03	$1.04	$-0.12	$0.08	$0.23	$-0.06	$-0.25	$0.31	$0.47	—
Free Cash Flow per Share (USD)	$2.59	$3.56	$3.01	$1.34	$1.48	$0.50	$0.00	$-0.19	$0.09	$0.38	—	—	—	—	—
Book Value per Share (USD)	—	—	—	—	$9.34	$8.47	$8.19	$7.13	$7.16	$7.12	$6.54	$6.31	$6.49	$6.05	—
Tangible Book Value per Share (USD)	—	—	—	—	$9.27	$8.39	$8.11	$7.04	$7.06	$7.03	$6.46	$6.21	$6.48	$6.04	—
Basic Weighted Avg Shares (shares)	46.74M	48.43M	48.27M	48.55M	47.78M	47.04M	46.98M	46.40M	46.11M	45.38M	44.96M	41.96M	38.71M	38.58M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$477.86M	$360.31M	$264.19M	$283.46M	$214.31M	$167.48M	$165.23M	$113.51M	$120.59M	$123.48M	$115.98M	$135.40M	$107.57M	—	—
LT Debt (USD)	$619.71M	$613.53M	$603.17M	$76.64M	$78.19M	$45.92M	$46.32M	—	—	—	$40.30M	$42.68M	—	—	—
Total Equity (USD)	—	—	—	—	$445.52M	$402.31M	$381.37M	$332.44M	$333.74M	$329.25M	$295.51M	$281.86M	$251.54M	$233.44M	$208.52M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$719.89M	$731.97M	$644.39M	$498.99M	$437.77M	$349.85M	$322.36M	$294.67M	$240.18M	$255.16M	$251.52M	$210.46M	$229.68M	$204.32M	—
Depreciation Expense (USD)	$31.65M	$28.25M	$25.74M	$12.60M	$10.22M	$9.03M	$7.06M	$6.05M	$12.95M	$12.05M	$11.31M	$12.53M	$11.17M	$9.66M	—
Net Income, GAAP (USD)	$98.09M	$159.52M	$137.54M	$91.39M	$62.12M	$1.40M	$48.94M	$-5.74M	$3.65M	$10.53M	$-2.79M	$-10.70M	$11.86M	$18.09M	—
Operating Cash Flow (USD)	$156.12M	$213.39M	$183.50M	$89.18M	$97.99M	$57.27M	$41.76M	$38.19M	$39.21M	$38.56M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters

Amphastar Pharmaceuticals, Inc.

Analytical Summary

15-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare AMPH with peers